Michael Farah

Board Member

Michael Farah has been involved in principal investing and investment banking since 2001. Prior to Linden, he was a Vice President at Metalmark Capital where he focused on healthcare investing. Mr. Farah began his career at UBS Investment Bank where he focused on M&A advisory and capital raising transactions for the healthcare sector and also spent three years with Summit Partners as a private equity associate.

Mr. Farah holds a Bachelor of Arts in Finance, with honors, from Carnegie Mellon University and an MBA from Harvard Business School.

Company Blog

November 27, 2019
The Right Time for Portugal-Born Pharma Projects to Step-Up to…
The Portuguese pharma industry has developed into a market of national and international products… Read More
November 25, 2019
Analytical Methods for the Investigation of Carcinogenic Nitrosamines in APIs…
Learn more about the analytical methods which can be utilised for the testing of… Read More
November 11, 2019
Three Steps Towards Fulfilling the EMA Nitrosamine Advice
How a results-driven, chemistry-based strategy will enable companies to meet MAH responsibilities with the… Read More
More Articles

UPCOMING Events

All Events
Contact Us